Study S000850

A Randomized Controlled, Open-label, Multi-center Study With 16-week Beinaglutide or Dulaglutide Assessing Effects on Glucose Control and Weight Loss in Type 2 Diabetes With Overweight or Obesity.

ClinicalTrials.gov record

Registration

Registration: NCT05005741
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: UNKNOWN
Enrollment: 120
Start: 2021-05-01
Primary completion: 2023-12-31
Lead sponsor: Second Xiangya Hospital of Central South University
Conditions: Diabetes Mellitus, Type 2; Overweight or Obesity
Interventions: DRUG:Beinaglutide; DRUG:Dulaglutide
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

haemoglobin A1c(HbA1c) [From baseline to 16 week.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.